Rocket Pharmaceuticals (RCKT) 2025 Conference September 03, 2025 03:20 PM ET Speaker0All right. I think we're ready to get started. Welcome, everyone. I'm Josh Schimmer from the Cantor Biotech Equity Research Team and very pleased to introduce from Rocket Pharmaceuticals, Gaurav Shah, Chief Executive Officer. Gaurav, great to see you again, as always, and a very recent, very positive update on the Danan syndrome program.So, us a quick snapshot of where ROCCAT is in advancing your gene therapy portfolio and ...